PenderFund Capital Management Ltd.
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1706164
VANCOUVER, A1
Position in ESPR
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$0
+$0 QoQ
Shares Held
3,884,508
-0.2% QoQ
Ownership
1.51%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PenderFund Capital Management Ltd. holds $95,774 across 3 Drug Manufacturers - Specialty & Generic names. ESPR ranks #3 (0.0% of the industry book) .
All Filings in ESPR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 3,884,508 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | — | 3,891,926 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 4,391,926 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | — | 6,676,519 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | — | 6,676,519 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | — | 2,000,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||